- The Importance of Defining Actionability as Related to Disclosure of ...🔍
- Stats & Data🔍
- International policies guiding the selection🔍
- ACMG Adds Three New Genes to Secondary Findings List🔍
- Secondary findings in 421 whole exome|sequenced Chinese children🔍
- A Practice of ACMG SF v3.0 List🔍
- Actionable Genotypes and Their Association with Life Span in Iceland🔍
- Ten Years of Incidental🔍
ACMG SF v3.2 list for reporting of secondary findings in clinical ...
The Importance of Defining Actionability as Related to Disclosure of ...
2021. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College ...
Stats & Data - Medical Genome Initiative
Up to 2-6%. of the population worldwide is affected by a rare disease ... ACMG SF v3.0 list for reporting of secondary findings in clinical exome and ...
International policies guiding the selection, analysis, and clinical ...
Figure 2 Recommendations for consent and analysis of secondary findings ... ACMG SF v3.1 list for reporting of secondary findings in clinical ...
ACMG Adds Three New Genes to Secondary Findings List
... secondary finding list, v3.2. Clinical labs are recommended to report secondary findings on genes catalogued on ACMG's list when conducting ...
Secondary findings in 421 whole exome-sequenced Chinese children
... list was defined according to the American College of Medical Genetics and Genomics (ACMG) recommendations for reporting secondary findings v2.0 ...
A Practice of ACMG SF v3.0 List - MDPI
The American College of Medical Genetics and Genomics (ACMG) has published a guideline for reporting secondary findings and recently updated an ...
Actionable Genotypes and Their Association with Life Span in Iceland
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of ...
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Med.
ACMG SF v3.1 list for reporting of secondary findings in clinical ...
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics ...
2 The ACMG SFWG and the BOD agree that timely updates to the SF list are increasingly important, which has led to the decision to separate the ...
The ACMG Secondary Findings list - National Academies
•Emphasized the ACMG SF list was not validated for general population screening. Established two WGs. – Genomic Screening of Asymptomatic Patients Working Group.
genetic-testing-exome-and-genome-sequencing-for-the-diagnosis ...
In 2022, ACMG published ACMG SF v3.1, an updated list of genes included in the secondary findings (SF), which added an additional 5 genes ...
Secondary Findings Using Broad Pan Cardiomyopathy and ...
2. Miller, DT ∙ Lee, K ∙ Chung, WK ... ACMG Secondary Findings Working Group. Acmg sf v3.0 list for reporting of secondary findings in clinical ...
GENOMIC DIAGNOSTIC LABORATORY - CHOP Medical Exome
Current ACMG Secondary Findings List v3.2 [Adapted from Miller 2023, PMID: 37347242]. Gene. Gene. MIM. Disease/Phenotype. Phenotype. Category. Inheritance. SF ...
Clinical exome-based panel testing for medically actionable ...
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of.
ACMG SFv3 Genes recommended for return of secondary findings in
RPE65-related retinopathy. Child. RPE65. AR. P and LP (2 ... ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a ...
Clinically actionable secondary findings in 130 triads from sub ...
TABLE 1. List of pathogenic and likely pathogenic variants according to the ACMG SFv3. · TABLE 2. Variants from the additional genes included in ...
ACMG releases update to secondary findings gene list - EurekAlert!
In May 2021, the ACMG's SFWG issued “ACMG SF v3.0 List for Reporting of Secondary Findings in Clinical Exome and Genome Sequencing: a Policy ...
The use of ACMG secondary findings recommendations for general ...
... (2):441-442. A comment on this article appears in "Response to Gomy and ... ACMG SF v3.1 list for reporting of secondary findings in clinical exome and ...
NIH researchers find many people want secondary genomic findings ...
... two groups: "reversible refusers" who switched their decision to ... ACMG SF v3.0 list for reporting of secondary findings in clinical ...